Less than 2% of the scientific research on breast cancer is devoted to discovery of its causes; rather, the overwhelming focus has been on early diagnosis and treatment of disease once it occurs.  This is certainly understandable; researchers must prioritize their efforts and resources and it is perfectly reasonable to focus first on those who are already ill.

However, it is impossible to "catch up" with the 1.3 million women who will be diagnosed with breast cancer around the world this year. The breast cancer epidemic is now so large that we simply must devote more research to discovery of the causes of breast cancer and focus on primary prevention.

It is part of the mission of the Breast Health & Healing Foundation to redirect the attention of the scientific community to discovery of the causes of breast cancer. 

The Breast Health & Healing Foundation is grateful for the support and expertise of our renowned scientific advisory board:

• Professor Beatriz G. Pogo
  Mt. Sinai Medical Center
  New York, NY
  
• Professor Paul Levine
  George Washington University Medical Center
  Washington, D.C.
  
• Professor Nancy Adler
  McGill University
  Montreal, Canada
  
• Dr. Joyce O'Shaughnessy
  Baylor Sammons Cancer Center
  Dallas, TX
• Professor James S. Lawson
  University of New South Wales
  Sydney, Australia
• Dr. Fatah Kashanchi
  George Washington University
  Washington, D.C.

Click here for more information and bios on our advisory board.

Breast Health & Healing Foundation has identified the following research into the causes of breast cancer, work that we encourage and support:

• Is aberrant hypermethylation an early event in breast cancer? 
  Sullivan RF, New York University Cancer Institute, New York, NY
  
  
• SNP microarray analysis of genomic alterations in infiltrating ductal carcinoma and infiltrating lobular carcinoma. 
  Tan CC, Fred Hutchinson Cancer Research Center, Seattle, WA
  
  
• Apocrine metaplasia and the development of ER-negative breast cancer. 
  Lee S, Baylor College of Medicine, Houston, TX
  Traditional Practice Alliance, Sacramento, CA
  
  
• Molecular alterations in columnar cell lesions of the breast. 
  Dabbs DJ, Magee-Women’s Hospital, Pittsburgh, PA
  
  
• Protein acetylation and hormone-independent breast cancer. 
  Cui Y, Baylor College of Medicine, Houston, TX
  
  
• Diet and global DNA methylation in breast cancer. 
  Germano PBMR, Universidad Federal de Sao Paulo, Sao Paulo, Brasil
  
  
• Molecular pathogenesis of breast cancer in women of African ancestry. 
  Ikpatt OF, Usman Danfodio Teaching Hospital, Sokoto, Nigeria
  Institute of Medical Research and Training, Ibadan, Oyo, Nigeria
  
  
• Differential gene expression in normal breast tissue from African American and Caucasian women. 
  Field LA, Walter Reed Army Medical Center, Washington, D.C
  
  
• 24.Genetic alterations associated with early hyperplastic precursors of breast cancer. 
  Lee S, Baylor College of Medicine, Houston, TX
  
  
• Lifestyle approaches to breast cancer risk reduction:  insights and opportunities.
  Bernstein L, USC/Norris Comprehensive Cancer Center, Los Angeles, CA
  
  
• Risk factors in breast cancer, a myth – an Indian experience. 
  Pant CS, Col Pant’s Imaging Centre, New Delhi, Delhi, India

Click here to return to top of the page

Click here to return to the top of the page.